# Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor

> **NCT06048367** · PHASE1 · COMPLETED · sponsor: **Sichuan Enray Pharmaceutical Sciences Company** · enrollment: 19 (actual)

## Conditions studied

- Advanced Solid Tumor
- Lung Cancer
- Pancreas Cancer
- Breast Cancer
- Thyroid Cancer
- Colorectal Cancer
- Cervical Cancer
- Ovarian Cancer
- Vulva Cancer

## Interventions

- **DRUG:** CNSI-Fe(II) 30 mg
- **DRUG:** CNSI-Fe(II) 60 mg
- **DRUG:** CNSI-Fe(II) 90 mg
- **DRUG:** CNSI-Fe(II) 120 mg
- **DRUG:** CNSI-Fe(II) 150 mg

## Key facts

- **NCT ID:** NCT06048367
- **Lead sponsor:** Sichuan Enray Pharmaceutical Sciences Company
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-17
- **Primary completion:** 2024-09-29
- **Final completion:** 2025-02-06
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06048367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06048367, "Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06048367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*